======= LTA4H =======
== Gene Information ==
* **Official Symbol**: LTA4H
* **Official Name**: leukotriene A4 hydrolase
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4048|4048]]
* **UniProt**: [[https://www.uniprot.org/uniprot/P09960|P09960]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=LTA4H&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LTA4H|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/151570|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene B4. Has also aminopeptidase activity. {ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:12207002, ECO:0000269|PubMed:15078870, ECO:0000269|PubMed:18804029, ECO:0000269|PubMed:1897988, ECO:0000269|PubMed:1975494, ECO:0000269|PubMed:2244921}.
|Leuk-A4-hydro C|
|Peptidase M1|
|leukotriene-A4 hydrolase activity|
|epoxide hydrolase activity|
|leukotriene biosynthetic process|
|metalloaminopeptidase activity|
|aminopeptidase activity|
|long-chain fatty acid biosynthetic process|
|peptide catabolic process|
|leukotriene metabolic process|
|icosanoid biosynthetic process|
|tertiary granule lumen|
|peptidase activity|
|fatty acid derivative biosynthetic process|
|icosanoid metabolic process|
|long-chain fatty acid metabolic process|
|fatty acid biosynthetic process|
|ficolin-1-rich granule lumen|
|fatty acid derivative metabolic process|
|monocarboxylic acid biosynthetic process|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|fatty acid metabolic process|
|neutrophil degranulation|
|neutrophil activation involved in immune response|
|neutrophil mediated immunity|
|neutrophil activation|
|granulocyte activation|
|leukocyte degranulation|
|myeloid leukocyte mediated immunity|
|myeloid cell activation involved in immune response|
|peptide metabolic process|
|monocarboxylic acid metabolic process|
|lipid biosynthetic process|
|myeloid leukocyte activation|
|small molecule biosynthetic process|
|leukocyte activation involved in immune response|
|cell activation involved in immune response|
|regulated exocytosis|
|leukocyte mediated immunity|
|cellular amide metabolic process|
|exocytosis|
|zinc ion binding|
|carboxylic acid metabolic process|
|leukocyte activation|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|secretion by cell|
|organic acid metabolic process|
|export from cell|
|organonitrogen compound catabolic process|
|cell activation|
|immune effector process|
|secretion|
|lipid metabolic process|
|proteolysis|
|RNA binding|
|small molecule metabolic process|
|organic substance catabolic process|
|cellular catabolic process|
|immune response|
|extracellular region|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|-1.92|
|[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|-1.73|
|[[:results:exp288|HMS-I2 10μM R06 exp288]]|-1.7|
|[[:results:exp224|CB-839 10μM R05 exp224]]|1.82|
|[[:results:exp375|Lenalidomide 20μM R07 exp375]]|1.83|
|[[:results:exp346|CoCl2 18μM R07 exp346]]|1.88|
^Gene^Correlation^
|[[:human genes:p:polr2j3|POLR2J3]]|0.411|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 12857
* **Expression level (log2 read counts)**: 7.17
{{:chemogenomics:nalm6 dist.png?nolink |}}